Vir Biotechnology, Inc. ($VIR)
O'Byrne Jason โ EVP & Chief Financial Officer
Shares
110,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 23, 2026
EPS:Est: -0.42
Revenue:Est: $19.91M
Feb 25, 2026
EPS:Est: -0.42
Transaction Details
| Insider | O'Byrne Jason |
|---|---|
| Title | EVP & Chief Financial Officer |
| Transaction Date | Feb 22, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 25, 2026 |
| Shares Purchased | 110,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 110,000 |
| Derivative | Derivative |
| Accession Number | 0001628280-26-011330 |
| Document | View SEC Filing |